Publications by authors named "Delin Min"

Claim this Profile
D
Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer.
Kunlin Liu, Chenhao Zhu, Yongxi Liang, Delin Min, Zijun Jin

J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACSS2 drives senescence-associated secretory phenotype by limiting purine biosynthesis through PAICS acetylation.
Li Yang, Jianwei You, Xincheng Yang, Ruishu Jiao, Jie Xu, Delin Min, Fuming Li

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel tubulin CBSI from the indanone scaffold for the treatment of colorectal cancer.
Zhipeng Huo, Delin Min, Shijie Zhang, Mei-Lin Tang, Xun Sun

RSC Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer.
Yongxi Liang, Delin Min, Hulin Fan, Kunlin Liu, Juchuanli Tu

Acta Pharm Sin B· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis